JAAOS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jacobs, J.
Right arrow Articles by Galante, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jacobs, J.
Right arrow Articles by Galante, J.

Wear Debris in Total Joint Replacements

JJ Jacobs, A Shanbhag, TT Glant, J Black and JO Galante

Rush-Presbyterian-St. Luke's Medical Center, Chicago.

In vivo degradation of prosthetic implant materials is increasingly recognized as a major factor limiting the durability of total joint arthroplasty. In vivo degradation occurs primarily by means of wear processes that can generate large quantities of particulate debris. This debris can stimulate an adverse local host response leading to periprosthetic bone loss, which can compromise implant fixation and bone stock. The authors review the basic mechanisms of implant degradation and the host response to particulate degradation products, particularly in the context of the pathogenesis of osteolysis. Submicron polyethylene particles (mean size, 0.5 um) are the dominant type of wear particle present in periprosthetic tissues associated with uncemented hip replacements. Polyethylene wear can be minimized by improving the quality of the polyethylene, avoiding use of large-diameter (greater than 28 mm) femoral heads in total hip arthroplasty, and improving the design and fabrication of modular connections, which can be important sources of three-body wear particles. Advances in the understanding of the basic mechanisms of osteolysis are critical to the development of preventive measures that will minimize the clinical impact of this phenomenon.




This article has been cited by other articles:


Home page
 JBJSHome page
K. W. Nam, J. J. Yoo, Y. Lae Kim, Y.-M. Kim, M.-H. Lee, and H. J. Kim
Alumina-Debris-Induced Osteolysis in Contemporary Alumina-on-Alumina Total Hip Arthroplasty. A Case Report
J. Bone Joint Surg. Am., November 1, 2007; 89(11): 2499 - 2503.
[Full Text] [PDF]

Home page
 JBJSHome page
M. W. Hanna and T. S. Thornhill
Thigh Mass and Lytic Diaphyseal Femoral Lesion Associated with Polyethylene Wear After Hybrid Total Knee Arthroplasty. A Case Report
J. Bone Joint Surg. Am., November 1, 2006; 88(11): 2473 - 2478.
[Full Text] [PDF]

Home page
 JBJSHome page
J. J. Yoo, Y.-M. Kim, K. S. Yoon, K.-H. Koo, W. S. Song, and H. J. Kim
Alumina-on-Alumina Total Hip Arthroplasty. A Five-Year Minimum Follow-up Study
J. Bone Joint Surg. Am., March 1, 2005; 87(3): 530 - 535.
[Abstract] [Full Text] [PDF]

Home page
 JBJSHome page
J. J. Yoo, H. J. Kim, and Y.-M. Kim
Damage of an Alumina-on-Alumina Bearing Surface from a Difficult Reduction of a Total Hip Arthroplasty. A Report of Three Cases
J. Bone Joint Surg. Am., February 1, 2004; 86(2): 376 - 378.
[Full Text] [PDF]

Home page
 JBJSHome page
R. A. Butler and R. L. Barrack
Total Hip Wear Debris Presenting as Lower Extremity Swelling. A Report of Two Cases
J. Bone Joint Surg. Am., January 1, 2004; 86(1): 142 - 145.
[Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
E. Grimaud, L. Soubigou, S. Couillaud, P. Coipeau, A. Moreau, N. Passuti, F. Gouin, F. Redini, and D. Heymann
Receptor Activator of Nuclear Factor {kappa}B Ligand (RANKL)/Osteoprotegerin (OPG) Ratio Is Increased in Severe Osteolysis
Am. J. Pathol., November 1, 2003; 163(5): 2021 - 2031.
[Abstract] [Full Text] [PDF]

Home page
 J Am Acad Orthop SurgHome page
R. Illgen II and H. E. Rubash
The Optimal Fixation of the Cementless Acetabular Component in Primary Total Hip Arthroplasty
J. Am. Acad. Ortho. Surg., January 1, 2002; 10(1): 43 - 56.
[Abstract] [Full Text] [PDF]

Home page
 JBJSHome page
J. A. Urban, K. L. Garvin, C. K. Boese, L. Bryson, D. R. Pedersen, J. J. Callaghan, and R. K. Miller
Ceramic-on-Polyethylene Bearing Surfaces in Total Hip Arthroplasty : Seventeen to Twenty-one-Year Results
J. Bone Joint Surg. Am., November 1, 2001; 83(11): 1688 - 1694.
[Abstract] [Full Text] [PDF]

Home page
 JBJSHome page
P. F. Pollice, R. N. Rosier, R. J. Looney, J. E. Puzas, E. M. Schwarz, and R. J. O'Keefe
Oral Pentoxifylline Inhibits Release of Tumor Necrosis Factor-Alpha from Human Peripheral Blood Monocytes : A Potential Treatment for Aseptic Loosening of Total Joint Components
J. Bone Joint Surg. Am., July 1, 2001; 83(7): 1057 - 1061.
[Abstract] [Full Text] [PDF]

Home page
 JBJSHome page
C. Vermes, R. Chandrasekaran, J. J. Jacobs, J. O. Galante, K. A. Roebuck, and T. T. Glant
The Effects of Particulate Wear Debris, Cytokines, and Growth Factors on the Functions of MG-63 Osteoblasts
J. Bone Joint Surg. Am., February 1, 2001; 83(2): 201 - 201.
[Abstract] [Full Text]

Home page
 ANN INTERN MEDHome page
D. T. Felson, R. C. Lawrence, M. C. Hochberg, T. McAlindon, P. A. Dieppe, M. A. Minor, S. N. Blair, B. M. Berman, J. F. Fries, M. Weinberger, et al.
Osteoarthritis: New Insights. Part 2: Treatment Approaches
Ann Intern Med, November 7, 2000; 133(9): 726 - 737.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
J.-W. Xu, J. Ma, T.-F. Li, E. Waris, A. Alberty, S. Santavirta, and Y. T Konttinen
Expression of epidermal growth factor and transforming growth factor alpha in interfacial membranes retrieved at revision total hip arthroplasty
Ann Rheum Dis, October 1, 2000; 59(10): 822 - 827.
[Abstract] [Full Text]

Home page
 JBJSHome page
J. J. JACOBS, A. K. SKIPOR, L. M. PATTERSON, N. J. HALLAB, W. G. PAPROSKY, J. BLACK, and J. O. GALANTE
Metal Release in Patients Who Have Had a Primary Total Hip Arthroplasty. A Prospective, Controlled, Longitudinal Study
J. Bone Joint Surg. Am., October 1, 1998; 80(10): 1447 - 58.
[Abstract] [Full Text]

Home page
 JBJSHome page
T. A. BLAINE, P. F. POLLICE, R. N. ROSIER, P. R. REYNOLDS, J. E. PUZAS, and R. J. O'KEEFE
Modulation of the Production of Cytokines in Titanium-Stimulated Human Peripheral Blood Monocytes by Pharmacological Agents. The Role of cAMP-Mediated Signaling Mechanisms*{{dagger}}
J. Bone Joint Surg. Am., October 1, 1997; 79(10): 1519 - 28.
[Abstract] [Full Text]

Home page
 JBJSHome page
D. R. DIDUCH, J. N. INSALL, W. N. SCOTT, G. R. SCUDERI, and D. FONT-RODRIGUEZ
Total Knee Replacement in Young, Active Patients. Long-Term Follow-up and Functional Outcome
J. Bone Joint Surg. Am., April 1, 1997; 79(4): 575 - 82.
[Abstract] [Full Text]

Home page
 JBJSHome page
G. S. TOMPKINS, J. J. JACOBS, L. R. KULL, A. G. ROSENBERG, and J. O. GALANTE
Primary Total Hip Arthroplasty with a Porous-Coated Acetabular Component. Seven-to-Ten-Year Results
J. Bone Joint Surg. Am., February 1, 1997; 79(2): 169 - 76.
[Abstract] [Full Text]

Home page
 JBJSHome page
C. J. SYCHTERZ, K. H. MOON, Y. HASHIMOTO, K. M. TEREFENKO, C. A. ENGH JR., and T. W. BAUER
Wear of Polyethylene Cups in Total Hip Arthroplasty. A Study of Specimens Retrieved Post Mortem
J. Bone Joint Surg. Am., August 1, 1996; 78(8): 1193 - 1200.
[Abstract] [Full Text]

Home page
 JBJSHome page
R. M. URBAN, J. J. JACOBS, D. R. SUMNER, C. L. PETERS, F. R. VOSS, and J. O. GALANTE
The Bone-Implant Interface of Femoral Stems with Non-Circumferential Porous Coating. A Study of Specimens Retrieved at Autopsy
J. Bone Joint Surg. Am., July 1, 1996; 78(7): 1068 - 81.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the American Academy of Orthopaedic Surgeons.